Sue Gail Eckhardt - Insider Trading & Ownership

Location
C/O Syros Pharmaceuticals, Inc., 35 Cambridgepark Drive, Cambridge, MA
Summary
The estimated net worth of Sue Gail Eckhardt is at least $1.01M dollars as of June 4, 2025. Sue Gail Eckhardt is the Director of EXELIXIS, INC. and owns shares of EXELIXIS, INC. (EXEL) stock worth about $934K. Sue Gail Eckhardt is the Director of Syros Pharmaceuticals, Inc. and owns shares of Syros Pharmaceuticals, Inc. (SYRS) stock worth about $79.2K.
Signature
/s/ Nina Ayer, Attorney in Fact
All Insider Reports
All Insider Reports

Ownership of Sue Gail Eckhardt

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
EXEL EXELIXIS, INC. Director $934K -$1.21M -56.5% Jun 2, 2025
SYRS Syros Pharmaceuticals, Inc. Director $79.2K Jun 5, 2024

Insider Transactions Reported by Sue Gail Eckhardt:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.